Roivant Sciences
Price & Volume
Stats
See more52W Range | $8.73-$16.79 |
Market Cap | $11B |
Shares Short | 27M |
Financials
See moreRevenue (12 Mos) | $23.2M |
Revenue Growth (YoY) | -72.8% |
Gross Profit (12 Mos) | -$555.9M |
Diluted EPS | -$1.10 |
News
See moreYahoo Finance • 8 days ago
Roivant Sciences files shelf registration for potential securities offerings
Yahoo Finance • 12 days ago
Vivek Ramaswamy's Bitcoin Play Just Got Bigger: This $1.3B Deal Could Signal Corporate Crypto's Next Phase
Yahoo Finance • 19 days ago
Monday 9/22 Insider Buying Report: HAIN, ROIV
Yahoo Finance • 24 days ago
Stocks Settle Mixed on Hawkish Fed Chair Powell Comments
About
CEO | Mr. Matthew Gline |
Address | 11-12 St. James's Square, London, United Kingdom, SW1Y 4LB |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 750 |
